LDL receptor family-dependent and -independent pathways for the internalization and digestion of lipoprotein lipase-associated β-VLDL by rat vascular smooth muscle cells

Journal of Lipid Research

Volumn 38, Issue 9, 1997, Pages 1841-1850

  Weaver, Alissa M ^a   Lysiak, Jeffrey J ^a   Gonias, Steven L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

2 macroglobulin; ACAT; Atherosclerosis; Cholesterol chylomi cron remnants; Low density lipoprotein receptor related protein; VLDL heparan sulfate proteoglycans; VLDL receptor

Indexed keywords

ALPHA 2 MACROGLOBULIN; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; CHYLOMICRON; HEPARIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL TRANSFORMATION; FOAM CELL; GENE EXPRESSION; IMMUNOBLOTTING; INTERNALIZATION; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR BINDING; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL ESTERS; GLUTATHIONE TRANSFERASE; HEPARAN SULFATE PROTEOGLYCANS; IODINE RADIOISOTOPES; LIPID METABOLISM; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; MUSCLE, SMOOTH, VASCULAR; RATS; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS;

EID: 0030821117     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
2. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation, 60: 473-485.
3. Davis, R. C., H. Wong, J. Nikazy, K. Wang, Q. Han, and M. C. Schotz. 1992. Chimeras of hepatic lipase and lipoprotein lipase. J. Biol. Chem. 267: 21499-21504.
4. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
5. 2-macroglobulin receptor in vitro. J. Biol. Chem. 268: 14168-14175.
6. Nykjaer, A., M. Nielsen, A. Lookene, N. Meyer, H. Roigaard, M. Etzerodt, U. Beisiegel, G. Olivecrona, and J. Gliemann. 1994. A carboxy-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. J. Biol. Chem. 269: 31747-31755.
7. Medh, J. D., S. L. Bowen, G. L. Fry, S. Ruben, M. Andracki, I. Inoue, J-M. Lalouel, D. K. Strickland, and D. A. Chappell. 1996. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J. Biol. Chem. 271: 17073-17080.
8. Strickland, D. K., M. Z. Kounnas, and W. S. Argraves. 1995. LDL receptor-related protein: a multifunctional receptor for lipoprotein and proteinase catabolism. FASEB J. 9: 890-898.
9. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors. Annu. Rev. Biochem. 63: 601-637.
10. Zhong-Sheng, J., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
11. Mulder, M., P. Lombardi, H. Jansen, T. J. C. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268: 9369-9375.
12. Berryman, D. E., and A. Bensadoun. 1995. Heparan sulfate proteoglycans are responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells. J. Biol. Chem. 270: 24525-24531.
13. Fernandez-Borja, M., D. Bellido, E. Vilella, G. Olivecrona, and S. Vilaro. 1996. Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway. J. Lipid Res. 37: 464-481.
14. Yanagishita, M., and V. C. Hascal. 1984. Metabolism of proteoglycans in rat ovarian granulosa cell culture: multiple intracellular degradative pathways and the effect of chloroquine. J. Biol. Chem. 259: 10270-10283.
15. Roghani, M., and D. Moscatelli. 1992. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267: 22156-22162.
16. Yanagashita, M. 1992. Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic and intracellular degradative pathways. J. Biol. Chem. 267: 9505-9511.
17. Gleizes, P-E., J. Noaillic-Depeyre, F. Amalric, and N. Gas. 1995. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach. Eur. J. Cell Biol. 66: 47-59.
18. Obunike, J. C., I. J. Edwards, S. C. Rumsety, L. K. Curtiss, W. D. Wagner, R. J. Deckelbaum, and I. J. Goldberg. 1994. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J. Biol. Chem. 269: 13129-13135.
19. Saxena, U., M. G. Klein, and I. J. Goldberg. 1990. Metabolism of endothelial cell-bound lipoprotein lipase. J. Biol. Chem. 22: 12880-12886.
20. 2-macroglobulin receptor. J. Biol. Chem. 266: 13936-13940.
21. Kutt, H., J. Herz, and K. K. Stanley. 1989. Structure of the low-density lipoprotein receptor-related promoter. Biochim. Biophys. Acta. 1009: 229-236.
22. 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J. Clin. Invest. 93: 2014-2021.
23. 2-macroglobulin receptor in human normal and atherosclerotic lesions. Arterioscler. Thromb. 14: 1438-1444.
24. Multhaupt, H. A. B., M. E. Gafvels, K. Kariko, H. Jin, C. Arenas-Elliott, B. I. Goldman, J. F. Strauss, B. Angelin, M. J. Warhol, and K. R. McCrae. 1996. Expression of very low density lipoprotein receptor in the vascular wall. Am. J. Pathol. 148: 1985-1997.
25. Stefansson, S., D. A. Chappell, K. M. Argraves, D. K. Strickland, and W. S. Argraves. 1995. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B-100. J. Biol. Chem. 270: 19417-19421.
26. 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42: 531-542.
27. Godyna, S., G. Liau, I. Popa, S. Stefansson, and W. S. Argraves. 1995. Identification of low density lipoprotein receptor-related protein (LRP) as an endocvtic receptor for thrombospondin-I. J. Cell. Biol. 129: 1403-1410.
28. 2-macroglobulin receptor-associated protein. J. Biol. Chem. 266: 13364-13369.
29. Willnow, T. E., A. Rohlmann, J. Horton, H. Otani, J. R. Brun, R. E. Hammer, and J. Herz. 1996. RAP, a specialized chaperone, prevents ligand-induced ER retention and digestion of LDL receptor-related endocvtic receptors. EMBO J. 15: 2632-2639.
30. Bu, G., H. J. Geuze, G. J. Strom, and A. L. Schwartz. 1995. The 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 14: 2269-2280.
31. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. J. Biol. Chem. 267: 9035-9040.
32. 2-macroglobulin receptor. J. Biol. Chem. 269: 12541-12547.
33. 2-macroglobulin and glycoprotein 330. J. Biol. Chem. 267: 21162-21166.
34. Battey, F. D., M. E. Gafvels, D. J. Fitzgerald, W. S. Argraves, D. A. Chappell, J. F. Strauss, and D. K. Strickland. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269: 23268-23273.
35. Medh, J. D., G. L. Fry, S. L. Bowen, M. W. Pladet, D. K. Strickland, and D. A. Chappell. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270: 536-540.
36. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
37. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
38. Ross, R. 1993. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant. Proc. 25: 2041-2043.
39. Taylor, R. G., W. G. Jerome, and J. C. Lewis. 1992. Ultrastructural localization of peroxidase in atherosclerotic lesions of pigeons. Exp. Mol. Pathol. 57: 167-179.
40. 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth factor-carrier activity. Eur. J. Biochem. 234: 714-722.
41. 2-macroglobulin. J. Biol. Chem. 256: 8134-8139.
42. 2-macroglobulin following reaction with methylamine and trypsin. Biochim. Biophys. Acta. 705: 306-314.
43. Geisterfer, A. A., M. J. Peach, and G. K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756.
44. Libby, P., and K. V. O'Brien. 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J. Cell. Physiol. 115: 217-223.
45. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to the low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
46. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
47. Weaver, A. M., M. McGabe, I. Kim, M. Allietta, and S. L. Gonias. 1996. Epidermal growth factor and platelet-derived growth factor-BB induce a stable increase in the activity of low density lipoprotein receptor-related protein in vascular smooth muscle cells by altering receptor distribution and recycling. J. Biol. Chem. 271: 24894-24900.
48. Gonias, S. L., L. L. Braud, W. A. Geary, and S. R. Vanden-Berg. 1989. Plasminogen binding to hepatocytes in culture and to thin slices of whole rat liver. Blood. 74: 729-736.
49. Ramirez-Zacarias, J. L., F. Castro-Munozledo, and W. Kuri-Harcuch. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97: 493-497.
50. 2-macroglobulin to hepatocytes: mechanism of in vivo clearance. Biochem. Biophys. Res. Commun. 128: 795-802.
51. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89: 9252-9256.
52. Matsuda, K. 1994. ACAT inhibitors as atherosclerotic agents: compounds and mechanisms. Med. Res. Rev. 14: 271-305.
53. Shimada, K., P. J. Gill, J. E. Silbert, and W. H. J. Douglas. 1981. Involvement of cell surface heparan sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J. Clin. Invest. 68: 995-1002.
54. Sehayek, E., T. Olivecrona, G. Bengtsson-Olivecrona, I. Vlodavasky, H. Levkovitz, R. Avner, and S. Eisenberg. 1995. Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures. Atherosclerosis. 114: 1-8.
55. Edwards, I. J., H. Xu, J. C. Obunike, I. R. Goldberg, and W. D. Wagner. 1995. Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arteriosder. Thromb. Vasc. Biol. 15: 400-409.
56. Wagner, W. D., and B. G. J. Salisbury. 1978. Aortic total glycosaminoglycan and dermatan sulfate changes in atherosclerotic rhesus monkeys. Lab. Invest. 39: 322-328.
57. Srinivasan, S. R., J-H. Xu, P. Vijaygopal, B. Radhakrishnamurthy, and G. S. Berenson. 1993. Injury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding property. Biochim. Biophys. Acta. 1168: 158-166.